Glibenclamide, a New Sulphonylurea: Whither Oral Hypoglycaemic Agents?

@article{Marble2012GlibenclamideAN,
  title={Glibenclamide, a New Sulphonylurea: Whither Oral Hypoglycaemic Agents?},
  author={Alexander Marble},
  journal={Drugs},
  year={2012},
  volume={1},
  pages={109-115}
}
Effectiveness and safety of glibenclamide for stroke: protocol for a systematic review and meta-analysis
TLDR
A systematic review using meta-analysis to assess the benefits and safety of glibenclamide as a neuroprotective drug and the outcomes will be mortality, scores from the Modified Rankin Scale and the occurrence of hypoglycaemic events.
Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies
TLDR
There is still a substantial need for the development of therapeutic agents for neuroprotection in acute ischemic stroke to protect the brain from damage prior to and during recanalization, extend the therapeutic time window for intervention and further improve functional outcome.
Radical–Radical Cross-Coupling Assisted N–S Bond Formation Using Alternating Current Protocol
Alternating current (AC) electrolysis is a promising, yet challenging, and under-developed protocol in organic synthesis. To achieve as high atom-efficiency as possible and avoid the use of externa...
Electro‐Stimulation, a Promising Therapeutic Treatment Modality for Tissue Repair: Emerging Roles of Sulfated Glycosaminoglycans as Electro‐Regulatory Mediators of Intrinsic Repair Processes
Glycosaminoglycans (GAGs) are a family of diverse biomolecules that decorate proteoglycans in the glycocalyx and extracellular matrix of all cells. They exist as linear polysaccharide chains
Solubility-Permeability Interplay of Hydrotropic Solubilization Using Response Surface Methodology
The solubility/dissolution of a drug in the gastrointestinal (GI) region and the permeability of a drug through the GI membrane are the two key parameters governing drug absorption. Poor aqueous
A diversity-oriented novel regioselective synthesis of sulfonamide–thiazolidinone hybrids
A regioselective multicomponent approach to sulfonamide–thiazolidinone hybrids has been developed.
BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema
TLDR
Emerging clinical data show that BIIB093 has the potential to transform the management of patients with LHI, contusion-TBI and other conditions in which swelling leads to neurological deterioration and death.
Glibenclamide ameliorates transplant-induced arteriosclerosis and inhibits macrophage migration and MCP-1 expression.
TLDR
Glibenclamide protected against aorta transplantation-induced arteriosclerosis by reducing inflammatory factors in vivo and inhibited macrophage migration and MCP-1 production in vitro.
4-Substituted and 1,4-Disubstituted Piperidines
This chapter describes methods of synthesis, pharmacological properties and the use of derivatives of 4-substituted and 1,4-disubstituted piperidines such as 4-piperidinols and their derivatives,
Diazabenzo[a]phenoxazone sulphonamides: synthesis, in-silico and in-vitro antimicrobial studies
The syntheses of new sulphonamide derivatives of 8,10-diazabenzo[a]phenoxazones are reported. The condensation of 4,5-diamino-6-hydroxy-2-mercaptopyrimidine and 2,3-dichloro-1,4-naphthoquinone in a
...
1
2
3
4
...

References

SHOWING 1-10 OF 24 REFERENCES
Angiopathy in
  • diabetes
  • 1970
Glibenclamide: Whither Oral Hypoglycaemic Agents
  • Diabetes 19:
  • 1970
Preliminary Clinical Evaluation of Glybenclamide in Treatment of Diabetes Mellitus
TLDR
The results to date do not suggest that this compound is clinically advantageous to other orally active hypoglycemic agents, but greatly enhanced activity compared to other sulfonylureas may be due to increased hydrophobic bonding to the receptor vicinity.
Statement on treatment of
  • Acta Medica Scandinavical
  • 1970
The University Group Diabetes Program : The effects of hypoglycemic agents on vascular complications in patients with adult onset diabetes . 2 . Findings at baseline ( Abstract )
  • 1970
The University Group Diabetes Program : The effects of hypoglycemic agents on vascular complications in patients with adult onset diabetes . I . Design and methods ( Abstract )
  • 1970
A new oral antidiabetic drug. (papers presented at the Tegernsee Conference, in Rottach-Egem
  • Germany, January
  • 1969
Comparative study of insulin secretion following repeated administration of glucose , tolbutamide and glibenclamide ( HB 419 ) in diabetic and non - diabetic human subjects
  • Hormone and Metabolic Research
  • 1969
Summary report of clinical investigation of the oral antidiabetic drug HB 419
  • Hormone and Metabolic Research 1 (Suppl. I):
  • 1969
...
1
2
3
...